← Leaderboards
Robert W. Doms
University Of Pennsylvania
$20,416,408
Attributed
$20,416,408
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–13$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$20,416,408 · 12
By mechanism
T32$7,453,865 · 2
R01$7,244,937 · 4
U19$1,653,028 · 1
U54$1,627,803 · 1
P01$1,020,450 · 2
U09$800,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Paul F Bates$14,487,725
- Irwin M Chaiken$15,499,914
- Meenhard Herlyn$50,214,821
- Sara Cherry$26,280,643
- Francisco A Gonzalez-Scarano$10,891,253
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineHuman Immunodeficiency Virus 1Tissue /Cell CultureCell TypeVirusCollaborationsTrainingViralCellsSimian Immunodeficiency VirusVirus Infection MechanismProtein Structure FunctionHiv Envelope ProteinCd4 MoleculeEmerging Communicable DiseasesMonoclonal AntibodyHiv-1Inhibitor/AntagonistCcr5 GeneGrantIn VitroExhibitsAffectFitness
Grant awards (64)
Training in HIV Pathogenesis$437,889
T32 · FY2013 · AI · contact PI
Interactions of Emerging Bunyaviruses with Host Cells$286,981
U54 · FY2013 · AI · contact PI
Finger Nucleases to Specifically Disrupt Coreceptor Expression$253,402
U19 · FY2013 · AI · contact PI
Training in Emerging Infectious Diseases$202,497
T32 · FY2013 · AI · contact PI
Training in HIV Pathogenesis$433,662
T32 · FY2012 · AI · contact PI
Interactions of Emerging Bunyaviruses with Host Cells$331,507
U54 · FY2012 · AI · contact PI
Finger Nucleases to Specifically Disrupt Coreceptor Expression$273,937
U19 · FY2012 · AI · contact PI
Training in emerging infectious diseases$236,745
T32 · FY2012 · AI · contact PI
Training in HIV Pathogenesis$427,831
T32 · FY2011 · AI · contact PI
Finger Nucleases to Specifically Disrupt Coreceptor Expression$364,387
U19 · FY2011 · AI · contact PI
Interactions of Emerging Bunyaviruses with Host Cells$336,540
U54 · FY2011 · AI · contact PI
Training in emerging infectious diseases$228,714
T32 · FY2011 · AI · contact PI
Training in HIV Pathogenesis$425,429
T32 · FY2010 · AI · contact PI
HIV entry and its inhibition$391,080
R01 · FY2010 · AI · contact PI
Finger Nucleases to Specifically Disrupt Coreceptor Expression$374,870
U19 · FY2010 · AI · contact PI
Interactions of Emerging Bunyaviruses with Host Cells$342,811
U54 · FY2010 · AI · contact PI
Training in emerging infectious diseases$172,722
T32 · FY2010 · AI · contact PI
Training in HIV pathogenesis$427,211
T32 · FY2009 · AI · contact PI
HIV entry and its inhibition$386,496
R01 · FY2009 · AI · contact PI
Finger Nucleases to Specifically Disrupt Coreceptor Expression$386,432
U19 · FY2009 · AI · contact PI
Interactions of Emerging Bunyaviruses with Host Cells$329,964
U54 · FY2009 · AI · contact PI
Training in emerging infectious diseases$241,365
T32 · FY2009 · AI · contact PI
Training in HIV pathogenesis$437,580
T32 · FY2008 · AI · contact PI
HIV entry and its inhibition$378,203
R01 · FY2008 · AI · contact PI
Training in emerging infectious diseases$234,665
T32 · FY2008 · AI · contact PI
HIV entry and its inhibition$377,207
R01 · FY2007 · AI · contact PI
Training in Emerging Infectious Diseases$239,912
T32 · FY2007 · AI · contact PI
Training in HIV pathogenesis$175,387
T32 · FY2007 · AI · contact PI
HIV entry and its inhibition$397,815
R01 · FY2006 · AI · contact PI
Training in HIV pathogenesis$333,943
T32 · FY2006 · AI · contact PI
Crimean congo hemorrhagic fever virus glycoproteins$304,423
R21 · FY2006 · AI · contact PI
Training in Emerging Infectious Diseases$237,548
T32 · FY2006 · AI · contact PI
CELL BIOLOGY OF AB PRODUCTION$191,204
P01 · FY2006 · AG · contact PI
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW$500,000
U09 · FY2005 · AI
Interactions Between HIV and SIV with DC-SIGN &DC-SIGNR$396,250
R01 · FY2005 · AI
Chemokine Receptors and HIV and SIV Infection$390,842
R01 · FY2005 · AI
Training in HIV pathogenesis$332,788
T32 · FY2005 · AI
Crimean congo hemorrhagic fever virus glycoproteins$311,902
R21 · FY2005 · AI
Training in Emerging Infectious Diseases$241,019
T32 · FY2005 · AI
Interactions Between HIV and SIV with DC-SIGN &DC-SIGNR$396,250
R01 · FY2004 · AI
Chemokine Receptors and HIV and SIV Infection$391,000
R01 · FY2004 · AI
TRAINING IN HIV PATHOGENESIS$325,683
T32 · FY2004 · AI
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW$300,000
U09 · FY2004 · AI
Training in Emerging Infectious Diseases$241,317
T32 · FY2004 · AI
Interactions Between HIV and SIV with DC-SIGN &DC-SIGNR$396,250
R01 · FY2003 · AI
Chemokine Receptors and HIV and SIV Infection$391,152
R01 · FY2003 · AI
TRAINING IN HIV PATHOGENESIS$314,975
T32 · FY2003 · AI
HIV-1 AND HIV-2 INFECTION OF NON-DIVIDING CELLS$272,425
R01 · FY2003 · AI
Training in Emerging Infectious Diseases$228,826
T32 · FY2003 · AI
Chemokine Receptors and HIV and SIV Infection$391,301
R01 · FY2002 · AI
Interactions Between HIV and SIV with DC-SIGN &DC-SIGNR$356,625
R01 · FY2002 · AI
TRAINING IN HIV PATHOGENESIS$321,733
T32 · FY2002 · AI
IMMUNIZATION AND HUMORAL RESPONSE TO HIV1 896 ENV$292,433
R01 · FY2002 · AI
BIOSYNTHESIS AND PROCESSING OF AB IN NT2N CELLS$196,218
P01 · FY2002 · AG
CHEMOKINE RECEPTORS AND HIV AND SIV INFECTION$364,730
R01 · FY2001 · AI
Interactions Between HIV and SIV with DC-SIGN &DC-SIGNR$356,625
R01 · FY2001 · AI
TRAINING IN HIV PATHOGENESIS$290,930
T32 · FY2001 · AI
IMMUNIZATION AND HUMORAL RESPONSE TO HIV1 896 ENV$285,441
R01 · FY2001 · AI
BIOSYNTHESIS AND PROCESSING OF AB IN NT2N CELLS$196,218
P01 · FY2001 · AG
CHEMOKINE RECEPTORS AND HIV AND SIV INFECTION$354,161
R01 · FY2000 · AI
IMMUNIZATION AND HUMORAL RESPONSE TO HIV1 896 ENV$278,651
R01 · FY2000 · AI
TRAINING IN HIV PATHOGENESIS$263,494
T32 · FY2000 · AI
BIOSYNTHESIS AND PROCESSING OF AB IN NT2N CELLS$240,592
P01 · FY2000 · AG
BIOSYNTHESIS AND PROCESSING OF AB IN NT2N CELLS$196,218
P01 · FY2000 · AG